Zobrazeno 1 - 10
of 22
pro vyhledávání: '"M R, Kilbourn"'
Autor:
S. B. Wilkinson, D. S. Sax, K. Kompoliti, C. Eberly, L. M. Shulman, S. A. Factor, K. K. Zakzanis, M. Brewer, C. DeCarti, M. Takanashi, S. A. Alsdorf, K. Frey, M. R. Kilbourn, C. Comella, G. P. Bates, W. M. Chung, A. S. Menon, C. B. Moskowitz, R. Schwartz, J. M. Bertoni, Tatiana Foroud, John Seibyl, A. Minagar, J. Kieltyka, P. M. Conneally, R. A. Hauser, H. Ellgring, W. J. Weiner, S. W. Davies, R. Pahwa, L. Quinn, M. Freedman, R. Innis, A. Willing, E. Kaplan, N. I. Bohnen, Paul J. Tuite, T. Yanagihara, J. H J Cha, J. Hubble, F. Cardoza, G. Rouleau, L. Mangiarini, E. Aylward, M. Guttman, G. Ulm, A. B. Young, B. Pfeiffer, A. Malik, Juan Sanchez-Ramos, A. S. Frey, J. B. Penney, A. I. Troster, K. Abe, G. Bates, K. Francis, K. E. Lyons, Roger L. Albin, W. C. Koller, C. Kornetsky, M. Seeland, L. Leach, K. A. Frey, M. Baehr, R. A. Koeppe, Karl Kieburtz, David Oakes, G. W. Paulson, E. R. Siemers, Joanne Wojcieszek, L. W. Elmer, T. A. Zesiewicz, Kenneth Marek, D. Strickland, Mark Stacy
Publikováno v:
Movement Disorders. 13:858-863
Publikováno v:
ChemInform. 25
Publikováno v:
Advances in neurology. 86
Quantitative measures of striatal VMAT2 binding sites appear to represent an excellent surrogate of nigrostriatal projection integrity in experimental animal models. Importantly, there does not appear to be a significant effect of dopaminergic drugs
Publikováno v:
Synapse (New York, N.Y.). 39(4)
Cerebral cholinergic deficits have been described in Alzheimer disease (AD) and as a result of normal aging. At the present time, there are very limited options for the quantification of cholinergic receptors with in vivo imaging techniques such as P
Publikováno v:
Annals of neurology. 48(3)
Based on surrogate assays of peripheral red blood cells, reports state that widely prescribed doses of donepezil hydrochloride provide nearly complete inhibition of cerebral cortical acetylcholinesterase activity in the treatment of Alzheimer's disea
Publikováno v:
Synapse (New York, N.Y.). 35(4)
The dose- and time-dependent changes of in vivo radioligand binding to the neuronal membrane dopamine transporter (DAT) and vesicular monoamine transporter type 2 (VMAT2) were examined in mouse brain after MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropy
Publikováno v:
Synapse (New York, N.Y.). 30(3)
Loss of cholinergic transmission in the cortex and hippocampus is a characteristic feature of Alzheimer's disease, and visualization of functional cholinergic synapses in the brain with PET could be a useful method for studying this degenerative cond
Publikováno v:
Synapse (New York, N.Y.). 30(2)
The effects of MPTP treatment (4 x 10 mg/kg, 2-h intervals) on in vivo striatal binding of (+)-alpha-[3H]dihydrotetrabenazine ((+)-[3H]DTBZ) to the vesicular monoamine transporter type 2 (VMAT2) were examined in wild type (+,+) and tottering (tg/tg)
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 38(4)
A two time-point sacrifice method is proposed as an alternative to conventional multiple time-point sacrifice methods to determine the organ cumulated activity of 11C-labeled radiopharmaceuticals.Rat biodistribution data for 10 11C-labeled radiopharm
Publikováno v:
Chirality. 9(1)
Chiral column liquid chromatography and enantiospecific enzymatic hydrolysis were utilized to separate the enantiomers of alpha- and beta-dihydrotetrabenazine and alpha-9-O-desmethyldihydrotetrabenazine, three benzo[a]quinolizines derived from the am